(Reuters) – Europe’s medicines regulator said on Thursday it has started a real-time review of the Sputnik V COVID-19 vaccine developed by Russia’s Gamaleya Institute for possible approval in the region.
(Reporting by Pushkala Aripaka in Bengaluru; Editing by Sriraj Kalluvila)
